Mason Michael 4
4 · Karyopharm Therapeutics Inc. · Filed Jun 6, 2022
Insider Transaction Report
Form 4
Mason Michael
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2022-06-03$6.07/sh−3$18→ 138,509 total - Sale
Common Stock
2022-06-03$6.04/sh−598$3,612→ 138,512 total
Footnotes (1)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.